Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekFiercePharma ↗
AstraZeneca has fired another shot in its bladder cancer competition with Merck's Keytruda, with the FDA clear…
The WeekFierceBiotech ↗
Pfizer is paying Innovent $650 million upfront to partner on cancer drug development, following Bristol Myers …
The WeekBriefing
Astellas targets $1.3B in savings through 2030 while Moderna’s mRNA flu vaccine faces advisory review. AstraZe…
The WeekAJMC ↗
Tobevibart-Elebsiran Sustains HDV Suppression at 96 Weeks: Tarik Asselah, MD, PhD…
The WeekDrug Channels ↗
Today's guest post comes from Angie Franks, Chief Executive Officer at Kalderos. As Angie explains, the indust…
The WeekDrug Channels ↗
Today's guest post comes from Angie Franks, Chief Executive Officer at Kalderos. As Angie explains, the indust…
The WeekSTAT News ↗
Long term, we don't know what tiny doses of GLP-1s for cosmetic weight loss can do, writes a weight-loss docto…
The WeekBioPharma Dive ↗
The findings supporting bepirovirsen were deemed a "historic moment" by physicians and validate a drug that ha…
The WeekFiercePharma ↗
Kaléo has launched the “AUVI-Q Speaks Up” campaign to share patients’, caregivers’ and healthcare providers’ s…
The WeekFierceBiotech ↗
GSK is pulling back the curtain on the phase 3 success of its chronic hepatitis B drug bepirovirsen, revealing…
The WeekBriefing
The FDA delayed a ruling on AstraZeneca’s camizestrant following a 6–3 advisory committee vote that found its …
The WeekSTAT News ↗
Here's what to watch for at ASCO, cancer research's big meeting, in Chicago.…
The WeekBioPharma Dive ↗
Formerly known as Verge Genomics, the new Verge Labs will help pharma and biotech partners match potential bra…
The WeekFiercePharma ↗
Amid an intensifying debate over how Washington should counter China’s rapid ascent in the biotech sector, a g…
The WeekFierceBiotech ↗
Kardigan may have only launched last year, but it seems the cardiovascular-focused biotech is already eyeing t…
The WeekBriefing
The agency delayed a verdict on AstraZeneca’s breast cancer drug following a 6–3 vote against approval, pendin…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D.Summer unofficially kicked off last weekend. So fire up the grill and enjoy these notewo…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D.Summer unofficially kicked off last weekend. So fire up the grill and enjoy these notewo…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D.Summer unofficially kicked off last weekend. So fire up the grill and enjoy these notewo…
The WeekSTAT News ↗
“Trump has willingly exposed an entire generation of children to Big Tobacco’s nicotine addiction,” writes Sen…
The WeekBioPharma Dive ↗
The base editing medicine lowered “bad” cholesterol levels along with a key protein, clearing the …
DealsBriefing
The pharma giant’s latest acquisitions of Curevo, LimmaTech, and Vaccine Company reinforce its pivot from trea…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.